What are the diagnostic changes for Avoidant/Restrictive Food Intake Disorder across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR, IV, V, V‑TR and the International Classification of Diseases (ICD) versions X and XI?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evolution of Avoidant/Restrictive Food Intake Disorder Diagnosis Across DSM and ICD Versions

Avoidant/Restrictive Food Intake Disorder (ARFID) is a new diagnostic entity that first appeared in DSM-5 (2013) and ICD-11 (2022), replacing the much narrower DSM-IV diagnosis of "Feeding Disorder of Infancy or Early Childhood" and having no equivalent in DSM-III, DSM-III-TR, or ICD-10. 1, 2, 3

DSM-III and DSM-III-TR (Text Revision)

  • ARFID did not exist as a diagnostic category in these versions 2, 3
  • No comparable diagnosis captured the clinical presentation of restrictive eating without body image concerns across the lifespan 4

DSM-IV

  • The predecessor diagnosis was "Feeding Disorder of Infancy or Early Childhood", which was severely limited in scope 2, 4, 3
  • This diagnosis was restricted to children 6 years of age or younger 4, 3
  • It required weight loss as a diagnostic criterion 4
  • The narrow age restriction and weight loss requirement left many patients with clinically significant restrictive eating "diagnostically orphaned" 4

DSM-5 (2013)

DSM-5 introduced ARFID as an entirely new diagnosis that dramatically expanded the diagnostic umbrella beyond its DSM-IV predecessor 1, 2, 3:

Key Diagnostic Criteria in DSM-5:

  • Abnormal eating or feeding behaviors resulting in insufficient quantity or variety of food to meet adequate energy or nutritional requirements 5, 6
  • Must result in at least one of the following:
    • Significant weight loss or failure to meet expected weight/height gain in children 5, 6
    • Significant nutritional deficiency 5, 6
    • Dependence on enteral feeding or oral nutritional supplements 5, 6
    • Marked interference with psychosocial functioning 5, 6

Critical Distinctions from Other Eating Disorders:

  • No body image distortion or fear of weight gain (distinguishing it from anorexia nervosa) 5, 6, 3
  • Not attributable to food availability or cultural practices 5
  • No age restriction—applicable to children, adolescents, and adults 1, 2, 3
  • No weight loss requirement 4

Clinical Significance of DSM-5 Changes:

  • The removal of age restrictions captured an older cohort accessing eating disorder clinics 4
  • The broader criteria provided a diagnostic home for previously unclassified pediatric feeding disorder subgroups 4
  • ARFID is recognized as highly heterogeneous, encompassing patients who avoid food based on sensory characteristics, fear of adverse consequences, or apparent lack of interest in eating 7

DSM-5-TR (Text Revision)

  • The evidence provided does not indicate substantive changes to ARFID diagnostic criteria between DSM-5 and DSM-5-TR 1, 2
  • The core diagnostic framework established in DSM-5 appears to have been maintained 2

ICD-10

  • ARFID did not exist as a distinct diagnostic category in ICD-10 5
  • Patients with restrictive eating without body image concerns lacked appropriate classification 4

ICD-11 (2022)

ICD-11 introduced ARFID as a new diagnostic category, defined as "characterized by abnormal eating or feeding behaviors resulting in the intake of an insufficient quantity or variety of food to meet adequate energy or nutritional requirements" 5:

  • This represents one of multiple new diagnostic categories added to the Mental, Behavioural or Neurodevelopmental Disorders chapter 5
  • The ICD-11 definition aligns conceptually with DSM-5 criteria, emphasizing insufficient intake without body image disturbance 5
  • ICD-11 maintained a largely categorical approach while adding dimensional expansions for some diagnoses, though specific dimensional qualifiers for ARFID are not detailed in the provided evidence 5

Clinical Implications of Diagnostic Evolution

Recognition Across the Lifespan:

  • The expansion from a pediatric-only diagnosis to one applicable across all ages fundamentally changed clinical practice 1, 2, 3
  • Adolescents and adults with restrictive eating patterns can now receive appropriate diagnosis and treatment 1, 2

Heterogeneity Challenges:

  • ARFID is widely recognized as lacking specificity, encompassing diverse presentations that may benefit from subtype differentiation 4, 7
  • The broad diagnostic umbrella, while capturing previously undiagnosed patients, creates challenges for targeted treatment development 4, 7

Common Diagnostic Pitfalls:

  • Do not overlook ARFID in older adolescents and adults—the diagnosis is not limited to young children 1, 2, 3
  • Carefully distinguish from anorexia nervosa—the absence of body image distortion and fear of weight gain is essential 5, 6, 3
  • Recognize that weight loss is not required—patients may present with nutritional deficiency, growth failure, or psychosocial impairment without significant weight loss 4
  • Consider the three main avoidance patterns: sensory-based avoidance, fear of aversive consequences (choking, vomiting), and lack of interest in eating 7

References

Research

Avoidant restrictive food intake disorder: an illustrative case example.

The International journal of eating disorders, 2013

Research

Avoidant/Restrictive Food Intake Disorder (ARFID).

Current problems in pediatric and adolescent health care, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Avoidant/Restrictive Food Intake Disorder (ARFID)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What eating disorder best accounts for a 5-year-old boy's presentation with failure to gain weight, purpuric lesions, gingival edema, generalized weakness, malaise, sadness, and bleeding during tooth brushing?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM‑5‑TR) and the International Classification of Diseases, Eleventh Revision (ICD‑11) in diagnosing Avoidant/Restrictive Food Intake Disorder?
What is Avoidant/Restrictive Food Intake Disorder (ARFID)?
What is African trypanosomiasis (Afrid)?
What is Avoidant/Restrictive Food Intake Disorder (ARFID)?
What is the maximum dose of enoxaparin for therapeutic and prophylactic use, considering patient age, weight, and renal function?
What is the recommended management for recurrent urticaria?
Is metformin safe for a postpartum woman with type 2 diabetes mellitus who is breastfeeding?
What is the optimal inpatient management plan for a 37‑year‑old Filipino man with severe methamphetamine dependence, marked hyperglycemia (capillary glucose 289–576 mg/dL, fasting ~319 mg/dL), elevated blood urea nitrogen, hypocalcemia, and otherwise normal laboratory studies, during his admission before transfer to a therapeutic community?
Does cefepime have activity against multidrug‑resistant (MDR) Gram‑negative organisms such as ESBL‑producing Enterobacteriaceae and Pseudomonas aeruginosa?
How should I manage a patient with a fasting blood glucose of 330 mg/dL and a post‑prandial glucose of 420 mg/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.